Anthem Blue Cross and Blue Shield Virginia prior authorization, page 70

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
P2031Hair AnalysisVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P2033Blood Thymol TurbidityVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P2038Blood MucoproteinVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P3000Screen Pap By Tech W Md SupvVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P3001Screening Pap Smear By PhysVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P7001Culture Bacterial UrineVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P9612Catheterize For Urine SpecVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
P9615Urine Specimen Collect MultVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q0111Wet Mounts/ W PreparationsVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q0114Fern TestVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q0115Post-Coital Mucous ExamVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q2026Injection, Radiesse, 0.1mlVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q2028Injection, sculptra, 0.5 mgVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 74 Original policy
Q2041Axicabtagene ciloleucel, up to 200 million autologous anti-CD19 CAR positive T cells, including leukapheresis and dose preparation procedures, per therapeutic doseVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2042Tisagenlecleucel, up to 600 million CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic doseVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2043Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2053Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2054Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic doseVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2055Idecabtagene vicleucel, up to 510 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, pVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2056Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation proceduresVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2057Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic doseVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q2058Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusionVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q3001Brachytherapy RadioelementsVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q3027Injection, interferon beta-1a, 1 mcg for intramuscular useVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q3028Injection, interferon beta-1a, 1 mcg for subcutaneous useVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4074Iloprost, Inhalation Solution, Fda-Approved Final Product, Non-Compounded, Administered Through Dme, Unit Dose Form, UpVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4081INJECTION, EPOETIN ALFA, 100 UNITS (FOR ESRD ON DIALYSIS)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4101Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4102Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4103Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4104Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4105Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4107Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4108Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4110Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4111Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4113GRAFTJACKET XPRESS, injectable, 1ccVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4114Integra flowable wound matrix, injectable, 1 ccVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4115Alloskin, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4116Alloderm, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4117Hyalomatrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4118Matristem micromatrix, 1 mgVirginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4121Theraskin, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4122Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4123Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4124Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4125Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4126Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4127Talymed, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy
Q4128Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure)Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 75 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.